ANGO

10.7400.19%
LP

Laura Piccinini

Senior VP and GM of Cardiovascular & International

Ms. Laura Piccinini was Independent Director of Senzime AB (publ) from August 31, 2022 to November 28, 2023. She was employed at Senzime AB (publ) until November 2023. She has been Senior Vice President and General Manager of Cardiovascular and International at AngioDynamics, Inc. since January 2024 and served as its General manager of Endovascular Therapies and International since June 1, 2021. Ms. Piccinini serves as a Director at Respiratory Motion, Inc., since 2020. She served as CEO & member of the Board of Directors for Respiratory Motion, Inc. and was Global Head of Commercial Operations for the Implants business unit at Nobel Biocare Systems (Danaher Company/Envista IPO). She has been the President of Developed Markets at Acelity Holdings, Inc., since September 2014. Ms. Piccinini served as President of Developed Markets for Acelity L.P. Inc. until February 21, 2017. Ms. Piccinini exposure in the medical device industry, with an extensive background in the field of respiratory and surgical care and served international leadership positions at Nellcor, Mallinckrodt, Tyco Healthcare, Stryker & Covidien. She led the European Medical Care Solutions and Operations at Covidien. Ms. Piccinini is a graduate of the Parma University of Medicine, where she received a nursing degree with specializations in ICU, Anesthesia and First Aid as a Helicopter Flight Coordinator.

Positions